Product Information
BUPROPION HCL SR 150 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.0824 per EA under NDC 43598075205. Its NADAC has been published 422 times since Jul 25, 2018.
FDA first approved this application on Mar 1, 2016. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598075205
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205794FDA Approved
3/1/2016
TE Code
AB1
On Market Since
5/15/2018
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL SR 150 MG TABLET has been published 422 times since Jul 25, 2018, and over the history we have for it it has declined 31.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0824 per EA |
|---|---|
| All-time high | $0.1252 (Sep 12, 2018) |
| All-time low | $0.0709 (May 22, 2024) |
| 52-week high | $0.0852 |
| 52-week low | $0.0805 |
| Median price | $0.0959 |
| Average price | $0.0995 |
| Largest weekly change | +20.0% (Jun 19, 2024) |
| Weeks tracked | 422 |
| Tracking since | Jul 25, 2018 |
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPROPION HCL SR 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 150 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.0824 per EA (NDC 43598075205), effective Aug 19, 2026.
How has the price of BUPROPION HCL SR 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL SR 150 MG TABLET has declined 31.1%. It has been tracked across 422 weekly CMS publications since Jul 25, 2018.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 150 MG TABLET?
Since Jul 25, 2018, the NADAC for BUPROPION HCL SR 150 MG TABLET has ranged from a low of $0.0709 (May 22, 2024) to a high of $0.1252 (Sep 12, 2018), with a median of $0.0959 per EA.
Are there cheaper alternatives to BUPROPION HCL SR 150 MG TABLET?
Yes. 14 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL XL 150 MG TABLET, is $0.0779 per EA — about 5% below BUPROPION HCL SR 150 MG TABLET.
Who manufactures BUPROPION HCL SR 150 MG TABLET?
BUPROPION HCL SR 150 MG TABLET (NDC 43598075205) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.